Thoughts On Synergy Pharma's Valuation As Cantor Initiates At Overweight

By: via Benzinga
Cantor Fitzgerald initiated coverage of Synergy Pharmaceuticals Inc (NASDAQ: SGYP) at Overweight with a price target of $11. Analyst ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.